Robotic-Assisted vs. Conventional: Comparing Zimmer Biomet Surgical Techniques for Knee Replacement

I coordinate perioperative services at a 400-bed teaching hospital. If you've ever wondered who makes sure the right implant, the right instruments, and the right robot end up in the right OR at the right time—that's me. I've managed more than 600 joint arthroplasty cases over 13 years, including the kind of emergencies that test whether a team's workflow can hold up under pressure.

Recently, one of our newer arthroplasty surgeons asked me a question I get from surgeons, administrators, and purchasing committees on a regular basis: "Honestly, should we be doing all our total knees with the ROSA robot, or is conventional technique just as good?"

That question is exactly why I'm writing this. I'm going to compare Zimmer Biomet's two approaches to total knee replacement—robotic-assisted surgical technique and the conventional manual technique—dimension by dimension. Not in a textbook way, but the way I'd explain it to a colleague who's sitting on a real capital decision.

What We're Comparing

Both approaches use the same Zimmer Biomet implants—most commonly the Persona total knee system, and the Oxford knee for partial replacements. The difference is entirely in how the bone cuts are planned and executed.

Conventional technique is the manually instrumented approach refined over decades. The surgeon uses intramedullary rods, alignment guides, and cutting blocks. They reference pre-operative X-rays, visually confirm anatomic landmarks, and make the cuts through fixed blocks. It's precision carpentry, guided by a well-trained eye.

ROSA robotic-assisted technique starts weeks before surgery with a CT scan. The surgeon imports the CT into ROSA's planning software, places the Persona components virtually on the patient's 3D bone model, and maps out the planned resections. In the OR, the surgeon registers the patient's landmarks to the CT data, and the robotic arm guides the saw using haptic feedback. The robot doesn't cut—it keeps the blade within the planned boundaries.

Both can produce excellent results. That's exactly why the comparison gets heated. So let's get into it.

Dimension 1: Surgical Precision and Alignment

This is the dimension robotic proponents cite most often, and the peer-reviewed data supports them. Multiple studies show robotic-assisted knee replacement achieves more accurate component positioning and more consistent mechanical alignment than conventional techniques.

It makes sense on a mechanical level. A CT-based plan eliminates most of the guesswork in determining the distal femoral resection angle or the tibial slope. The robotic arm prevents the saw from straying beyond the plan. The resulting cuts consistently land within 1–2 degrees of the target.

Conventional technique is more variable. A highly experienced surgeon can achieve excellent alignment most of the time, and I've seen radiographs of manual knees that look textbook-perfect. But the alignment curve has more outliers, and the outcome depends more heavily on the individual surgeon's judgment on any given day.

Conclusion: robotic-assisted wins on precision and reproducibility. The nuance is that nobody has conclusively proven those sub-degree improvements translate into higher patient satisfaction at five years. That doesn't mean they don't matter. It just means it's not the slam-dunk that sales materials suggest.

Dimension 2: OR Time and Workflow Resilience

Here's where my world comes in. In my role coordinating surgical services, the difference between a 90-minute knee and a 130-minute knee matters enormously.

ROSA cases add 15 to 25 minutes on average: CT verification, robot draping, landmark registration, and positioning the navigation camera. A surgeon doing three knees a day feels that schedule pressure immediately.

Conventional cases start faster. You check X-rays, palpate the landmarks, place the cutting block, and make the first cut within minutes. There's no registration step, no camera alignment, no robotic arm to maneuver around. When time is tight, conventional is quicker to mobilize.

That urgency isn't hypothetical. In February 2024, our ROSA system's navigation camera lost calibration 40 minutes before a scheduled knee replacement—mid-draping. The surgeon looked at me and asked, "Can we make this work?" We made the call together: convert to conventional. We pulled the manual Persona instrument set, rearranged the room, and made skin incision 17 minutes later than planned. The patient never knew anything changed. The case went perfectly fine.

I've also seen the reverse. A complex deformity case where the ROSA plan helped the surgeon avoid three trial reductions and 20 extra minutes of fiddling with component fit. In those situations, robotic actually saves time.

Conclusion: conventional wins on average OR time and is far easier to rescue when things go wrong. Robotic wins in anatomically complex cases, where planning precision reduces intraoperative guesswork.

Here's something most people don't realize: our division almost lost a major joint replacement program contract in 2023 because we tried to cut costs on the robotic service plan instead of paying for the premium support package. The robot went down twice in one month, and two surgeons started booking cases at an outpatient surgery center across town. That's when we implemented our "robot backup always ready" policy. Every robotic case now has a full manual instrument set pulled and ready in the case cart. We lost those two surgeons for three months, and it was a painful lesson.

Dimension 3: The Learning Curve

This might be the least discussed and most consequential dimension in a real hospital setting.

For surgeons trained in conventional arthroplasty—which is essentially every surgeon over 35—ROSA asks them to learn a new workflow. It's not harder surgery. It's different surgery. A surgeon who's done 1,000 conventional knees has a deeply ingrained mental model of where the cuts should go. Robotic technique asks them to trust an on-screen plan over their proprioception.

And the learning curve isn't just the surgeon. It's the entire team. The scrub tech has to learn new instruments. The circulator needs to know which cable goes where. The anesthesia team has to position the vital signs monitor and its cables so they don't interfere with the robot's cameras and movement. The first 10 to 15 robotic cases at any facility are measurably slower, and there's a subtle but real increase in tension in the room.

Younger surgeons tend to adopt robotic technique faster. Some of our surgeons near retirement looked at the learning curve and made a completely legitimate call: "I have 400 knees left in me. I'm not spending 40 of them on a learning curve."

Conclusion: robotic has a steeper team learning curve, and there's a real subset of experienced surgeons who will never adopt it. Forcing them is a waste of money and goodwill.

Dimension 4: Patient Monitoring, Vital Signs, and the Spirometry Question

Patient monitoring is rarely part of the "robotic vs. conventional" conversation, but it should be.

Regardless of technique, every patient is connected to a vital signs monitor from the moment they enter the OR. The monitor continuously tracks heart rate, blood pressure, oxygen saturation, ECG rhythm, and end-tidal CO2. This is identical for robotic and conventional cases. The robot does not change the anesthesia requirements.

What changes is logistics. With ROSA, the robotic arm and navigation camera take up additional floor space, and the anesthesia provider needs to arrange monitor cables carefully so they don't interfere with the robot's tracking. It's a minor thing, but it's worth a pre-case huddle, especially for teams new to robotics. I remember one of our first robotic cases: the circulator accidentally bumped the navigation camera, and registration had to be redone. (Which, honestly, was exactly the kind of mistake that teaches a team to protect the tracking line.)

On the pre-operative side, every knee replacement candidate gets a pulmonary function screening, typically with a spirometer. Here's how a spirometer works: the patient takes a deep breath, seals their lips around the mouthpiece, and blows out as hard and fast as possible. The device measures two key values—forced vital capacity (FVC), the total volume of air expelled, and forced expiratory volume in one second (FEV1). Those numbers tell the anesthesia team whether the patient's respiratory function can tolerate sedation and the physiological demands of surgery. A low FEV1 often triggers a pulmonology consult and, in severe cases, postponement of the procedure.

Conclusion: monitoring requirements and pre-operative screening are the same for both techniques. The differences are logistical—cables, space, and room layout. Plan for them, and you'll never feel the difference.

Dimension 5: Cost and Return on Investment

This is the uncomfortable one, but somebody has to talk about it.

Conventional knee replacement uses reusable instrument trays that amortize with volume. Your primary costs are implants, OR time, staffing, and the facility.

ROSA is a different financial animal. The capital acquisition cost is substantial—in the high six figures to seven figures, depending on configuration and negotiated terms. Service contracts, per-case instrument pieces, training, and IT infrastructure add ongoing costs. And the per-case cost math changes meaningfully when you spread it across 100 cases instead of 500.

Honestly, I'm not sure why some lower-volume facilities still bring in robotics. My best guess is surgeon recruitment pressure and market differentiation—they want the robot as a headline in their marketing. But the ROI modeling I've seen suggests you need roughly 400 or more total joints per year to make the economics defensible. Below 200, it's very difficult to justify.

Here's something vendors won't tell you in the first meeting: the quoted price is almost never the final price. Capital equipment purchases have negotiation room, and multi-year service agreements can be structured a number of ways. But discounting doesn't change the fundamental math. Robotics earns its keep at volume, and not below.

Conclusion: for high-volume joint programs, ROSA can be a reasonable investment. For low-volume programs, conventional is the financially sound choice.

Which One Should You Choose?

Here's where I intentionally frustrate anyone who wants a simple verdict. My recommendation is not "buy the robot" or "skip the robot." It's decide based on your numbers, your team, and your patient population.

Choose robotic-assisted (ROSA) if:

• Your total knee volume is high enough to spread the capital cost—I'd want at least 400 cases annually
• You have two or more surgeons genuinely committed to the learning curve, not just doing it because the hospital bought a robot
• You see a meaningful number of complex deformities where CT-based planning makes a real difference
• Your team, including anesthesia and circulating nurses, has bandwidth for training and workflow redesign

Choose conventional technique if:

• Your volume is under roughly 200 total knees per year
• OR time is consistently tight and every additional 20 minutes has real cost and schedule impact
• Your lead surgeons are late-career and not interested in changing their workflow
• You don't have technical support coverage for maintaining a robotic platform

If you're not sure where your facility falls, start with the Zimmer Biomet official website. They publish the complete surgical technique guides for both the ROSA robotic procedure and the conventional Persona approach. Reading those side by side teaches you more about the workflow difference than any sales brochure or webinar.

A Final Thought

I've seen surgeons do beautiful knees with conventional instruments. I've watched robotic-assisted teams execute what can only be described as technically flawless total knee replacements. I've also stood in an OR where the robot miscalibrated, and watched a staff convert to a manual approach in 17 minutes because we'd prepared for that exact scenario.

There is no absolute best technique. There is only the right technique for a particular hospital, with a particular team, at a particular moment. Anyone who tells you otherwise is trying to sell you something—quite literally.